Mivavotinib

SI-6313

Mivavotinib, >98% (HPLC)

CAS No. : [1312691-33-0]

Synonyms : TAK-659; CB-659

IUPAC Name : 6-(((1R,2S)-2-Aminocyclohexyl)amino)-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
250MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
500MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : TAK‑659 potently and selectively inhibits SYK and FLT3 at low‑nanomolar concentrations and triggers apoptosis preferentially in tumor cells. Its dual‑kinase activity and oral availability make it a valuable tool for studying CLL and related hematologic cancers.

References : Lam B. et al.: Bioorg. Med. Chem. Lett., 26(24), 5947-5950, 2016; Purroy N. et al.: Oncotarget., 8(1), 742-756, 2017; Yu J. et al.: Journal of Clinical Oncology, 34(15), e14091, 2016; Cen O. et al.: mSphere., 3(4), 2018.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.